ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | +600.0% | 435 | +559.1% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 66 | -40.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 110 | -41.8% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 189 | +33.1% | 0.00% | – |
| Q3 2021 | $2,000 | -85.7% | 142 | -74.6% | 0.00% | -100.0% |
| Q2 2021 | $14,000 | +366.7% | 560 | +321.1% | 0.00% | – |
| Q1 2021 | $3,000 | -50.0% | 133 | +25.5% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | +200.0% | 106 | +158.5% | 0.00% | – |
| Q3 2020 | $2,000 | -95.1% | 41 | -95.8% | 0.00% | -100.0% |
| Q1 2020 | $41,000 | -14.6% | 968 | -15.8% | 0.01% | +16.7% |
| Q4 2019 | $48,000 | +41.2% | 1,149 | +18.7% | 0.01% | +20.0% |
| Q3 2019 | $34,000 | +36.0% | 968 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $25,000 | -62.7% | 968 | -58.7% | 0.00% | -88.2% |
| Q4 2016 | $67,000 | -17.3% | 2,345 | -9.1% | 0.03% | -35.8% |
| Q3 2016 | $81,000 | +1057.1% | 2,581 | +1022.2% | 0.05% | +960.0% |
| Q2 2016 | $7,000 | +16.7% | 230 | +28.5% | 0.01% | +25.0% |
| Q4 2015 | $6,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |